KIFS Result update of Sun Pharma Q1 FY12

Please Share:: India Equity Research Reports, IPO and Stock News
Visit http://indiaer.blogspot.com/ for complete details �� ��

KIFS Result update of Sun Pharma Q1 FY12.

OVERVIEW

SunPharma ia an international, integrated, speciality pharmaceutical company. It manufactures and markets a large basket of pharmaceutical formulations as branded generics as well as generics in India, US and several other markets across the world. In India, the company is lende n niche therapy areas of psychiatry, neurology, cardiology, ets. The company has strong skills in product development, process chemistry and manufacturing of complex API as well as dosage forms.

Key highlights:

· Total income grew by 20% Y-o-Y to Rs. 1636 cr  v/s Rs. 1365 cr in June-10

· Operating Profit grew by 3% Y-o-Y to Rs. 644 cr. v/s Rs. 628 cr. in    Jun-10

· OPM fell by 658 bps   Y-o-Y to 39.39 % v/s 45.97 % in June-10

· Net profit fell by 2% Y-o-Y to Rs. 565 cr.  v/s Rs. 578 cr. in June-10

· NPM fell by 776 bps       Y-o-Y to 34.56 % v/s 42.32 % in June-10

Thanks and Regards,

KIFS Research